Being a GLP-1 analog, the medication is effective in managing blood glucose levels in patients with type 2 diabetes
Liraglutide and Semaglutide are both glucagon-like peptide-1 (GLP-1) receptor agonists, which are medications designed to improve glycemic control and promote weight loss in individuals with type 2 diabetes and obesity
This research not only provides a comprehensive perspective on the current status and trends of occupational noise-related disease burdens but also offers scientific insights for policymakers and public health managers, advancing the shared goals of global occupational health and health equity
Phosphorylation of IGF-IR/InsR is elevated in ER+ breast cancer cells resistant to estrogen deprivation and tamoxifen, possibly due to increased secretion of IGF1/2 in these cells and elevated expression of retinoblastoma-binding protein 2 that inhibits IGFBP4/5 by interacting with ER-NRIP1-HDAC1 complex [107,108,109]
However, ongoing research is needed to better understand how these findings translate to human health outcomes